SCHEMBL15053155

SCHEMBL15053155

O=CCCc1cccc2c1CCC(NS(=O)(=O)c1ccc(F)cc1)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 13/20 0.59
RB1 P06400 1/20 0.48
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
PTGDR Q13258 3/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.43
DRD2 P14416 3/20 0.42
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
HTR6 P50406 1/20 0.42
ABCB11 O95342 1/20 0.42
CYP2C9 P11712 1/20 0.42
DRD1 P21728 1/20 0.42
CCKAR P32238 1/20 0.42
DRD3 P35462 3/20 0.40
HTR1D P28221 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15078823 0.90 TBXA2R (0.73) TBXA2RPSEN1PSEN2APH1BNCSTN
SCHEMBL530795 0.90 TBXA2R (0.73) TBXA2RPSEN1PSEN2APH1BNCSTN
SCHEMBL15053303 0.89 TBXA2R (0.56) TBXA2RRB1DRD2DRD3HTR1D
SCHEMBL15051975 0.85 TBXA2R (0.62) TBXA2RRB1PSEN1PSEN2APH1B
SCHEMBL15052228 0.84 TBXA2R (0.81) TBXA2RRB1PTGDRPTGDR2ABCB11
SCHEMBL15052335 0.82 TBXA2R (0.58) TBXA2RRB1PSEN1PSEN2APH1B
SCHEMBL15052154 0.80 TBXA2R (0.53) TBXA2RRB1PSEN1PSEN2APH1B
SCHEMBL15052559 0.80 TBXA2R (0.62) TBXA2RRB1PTGDRPTGDR2ABCB11
SCHEMBL15052127 0.78 TBXA2R (0.73) TBXA2RCYP2C9
SCHEMBL15131733 0.77 TBXA2R (0.76) TBXA2RPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8927586-B2 Thromboxane A2 (TP) receptor antagonists THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-01-06 US disclosed
US-20130190370-A1 Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-07-25 US disclosed
US-20130165488-A1 Novel Thromboxane A2 (TP) Receptor Antagonists THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190370-A1 Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor TBXA2R, PTGIR, PTGFR TBXA2R 1/4885RB1 1741/4885PSEN1 2423/4885
US-20130165488-A1 Novel Thromboxane A2 (TP) Receptor Antagonists TBXA2R, TBXAS1, PTGIR TBXA2R 1/4885RB1 4111/4885PSEN1 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.